Phase 1 Degenerative disease Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Phase 1 Study to Investigate SIR4156 in Healthy Adult and Elderly Participants

Muscle degenerative diseases

Sironax Aus Pty Ltd132 enrolled1 locationACTRN12624001334594

Completed

Phase 1

A Randomized, Double-Blind and Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIR9900 after Oral Administrations in Healthy Adult Volunteers

Inflammatory diseases, particularly in central nervous systemDegenerative diseases, particularly in central nervous system.

Sironax Aus Pty Ltd80 enrolled1 locationACTRN12623000696695

Completed

Phase 1

A Study to Investigate the Safety of SIR2446M in Healthy Volunteers

Degenerative disease

Sironax Aus Pty Ltd114 enrolled2 locationsACTRN12621001621808